Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BioSig Technologies, Inc. - Common Stock (NQ:BSGM)

0.4938 +0.0038 (+0.78%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about BioSig Technologies, Inc. - Common Stock

< Previous 1 2 Next >
New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating Arrhythmias
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig to Highlight New Data from the PURE EP™ Platform at Heart Rhythm 2023
Leading physicians from Cleveland Clinic to present data from three posters that showcase the Company’s novel PURE EP™ Platform 
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Announces New Advisory Board Member Edwin Wang
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Announces New Advisory Board Member Lorraine Spurge
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Confirms No Exposure to Silicon Valley Bank
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Regains Compliance With All Nasdaq Listing Standards
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Awarded US Patent Claims for its Universal Notch Filter Technology
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Appoints Former Qorvo CFO as Successor to Steve Chaussy
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP™ Technology
From BioSig Technologies, Inc.
Via GlobeNewswire
Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Heart Rhythm Society Conference 
From BioSig Technologies, Inc.
Via GlobeNewswire
Global Cardiac Arrhythmia Monitoring Devices Market Size Expected to Reach $11.4 Billion by 2030
Palm Beach, FL – December 14, 2022 – FinancialNewsMedia.com News Commentary – A cardiac arrhythmia is an irregular heartbeat caused by incorrect electrical signals that govern the beats of the heart.... 
Via FinancialNewsMedia
BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
Abstract highlights promising results from PURE EP™ study at premier Asia-Pacific Heart Rhythm Society Conference 
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig’s PURE EP™ System Highlighted in the Journal of Atrial Fibrillation & Electrophysiology
Clinical abstract focuses on value of PURE EP™’s and its groundbreaking High Frequency Algorithm (HFA) during pulmonary vein isolation 
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Signs Master Research Agreement with Cleveland Clinic to Explore Expanded Applications for its Digital Signal Processing Technology
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Invited to Attend and Sponsor Venice Arrhythmias 2022
Company to introduce its novel digital signal processing technology to the European EP community at world-renown international congress 
From BioSig Technologies, Inc.
Via GlobeNewswire
BioSig Executes Purchase Agreement with Methodist Hospital, San Antonio and Expands Customer Base
Leading medical center in San Antonio acquires BioSig’s novel digital signal processing technology for arrhythmia care 
From BioSig Technologies, Inc.
Via GlobeNewswire
This NASDAQ is Cardiac Worthy: Patent Protected Signal Processing Advancements for Cardiac Arrhythmia Nearing Commercialization: BioSig Technologies (NASDAQ: BSGM)
Via Get News
Topics Intellectual Property
Exposures Intellectual Property
BioSig Expands its Installation Base in Texas
Signs a new installation agreement with high-volume center in San Antonio Westport, CT – November 04, 2021 – BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology... 
Via FinancialNewsMedia
Increasing Incidences of Cardiac Arrhythmias Raising Demand for Electrophysiology Medical Devices
Via FinancialNewsMedia
Atrial Fibrillation Market Is Expected To Reach  $11.123 Billion At A CAGR 11.2 % Through 2023
Palm Beach, FL – November 4, 2021 – FinancialNewsMedia.com News Commentary – Atrial fibrillation is an ailment in which the heart beats irregularly, unlike the usual heartbeat. The upper chambers of... 
Via FinancialNewsMedia
Topics Death
Exposures Death
BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors
Via FinancialNewsMedia
The Global Electrophysiology Market Is Projected To Reach $10.6 Billion By 2025
Via FinancialNewsMedia
BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology
Via FinancialNewsMedia
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.